Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NYSE - Nasdaq Real Time Price USD

Bio-Rad Laboratories, Inc. (BIO)

232.55
+0.98
+(0.42%)
At close: May 7 at 4:00:02 PM EDT
232.85
+0.30
+(0.13%)
Pre-Market: 5:13:45 AM EDT
Loading Chart for BIO
  • Previous Close 231.57
  • Open 235.66
  • Bid --
  • Ask --
  • Day's Range 229.84 - 236.15
  • 52 Week Range 215.38 - 387.99
  • Volume 280,579
  • Avg. Volume 388,045
  • Market Cap (intraday) 6.338B
  • Beta (5Y Monthly) 1.00
  • PE Ratio (TTM) --
  • EPS (TTM) -76.53
  • Earnings Date Jul 30, 2025 - Aug 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 318.67

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

www.bio-rad.com

7,700

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BIO

View More

Performance Overview: BIO

Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BIO
29.21%
S&P 500 (^GSPC)
4.26%

1-Year Return

BIO
16.92%
S&P 500 (^GSPC)
8.55%

3-Year Return

BIO
53.63%
S&P 500 (^GSPC)
36.57%

5-Year Return

BIO
49.49%
S&P 500 (^GSPC)
95.45%

Compare To: BIO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BIO

View More

Valuation Measures

Annual
As of 5/7/2025
  • Market Cap

    6.34B

  • Enterprise Value

    6.05B

  • Trailing P/E

    --

  • Forward P/E

    29.85

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.57

  • Price/Book (mrq)

    0.95

  • Enterprise Value/Revenue

    2.38

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -85.16%

  • Return on Assets (ttm)

    1.55%

  • Return on Equity (ttm)

    -27.52%

  • Revenue (ttm)

    2.54B

  • Net Income Avi to Common (ttm)

    -2.16B

  • Diluted EPS (ttm)

    -76.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.66B

  • Total Debt/Equity (mrq)

    20.50%

  • Levered Free Cash Flow (ttm)

    250.23M

Research Analysis: BIO

View More

Company Insights: BIO

Research Reports: BIO

View More

People Also Watch